Mandate

Vinge advises Bonhams 1793 Limited in connection with its acquisition of Bukowski

January 11, 2022 M&A

Vinge has advised Bonhams 1793 Limited, an international auction house with its head office in London, and a portfolio company of Epiris LLP, in connection with its acquisition of Bukowski Auktioner Aktiebolag (”Bukowski”).

Bukowski is an auction house within art and antiquities with its head office in Berzelii Park in Stockholm. The company also has a Finnish Subsidiary, Bukowski Oy. Through the acquisition, Bonhams will extend its geographical presence in Europe.

Vinge’s team consisted of, among others, Christina Kokko, Isabelle Wållgren, Hannah Kajlinger, Christa Anttila, Vilhelm Rondahl and Ellen Åkerdahl Flygt (M&A), Anton Sjökvist and Caroline Krassén (Financial Services), Tove Lövgren Frisk (Compliance), Karl-Hugo Engdahl (GDPR, IT), Ulf Pyk (Real Estate), Karolina Fuhrman and Isabell Nielsen (Corporate Commercial), Arvid Axelryd (IP), Emil Lindvall and Gustav Lindgren (Employment) as well as Sara Dahlros Sköld (VDR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026